June 9, 2020 / 3:29 PM / 2 months ago

BRIEF-Barda Says It Awards $23.7 Mln To Support Development Of AstraZeneca USA'S SARS-COV-2 Monoclonal Antibody Combination

June 9 (Reuters) - BARDA:

* BARDA SAYS IT AWARDS $23.7 MILLION TO SUPPORT DEVELOPMENT OF ASTRAZENECA USA'S SARS-COV-2 MONOCLONAL ANTIBODY COMBINATION Source text: (bit.ly/2zlHr5a) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below